Becton Dickinson & Co. (NYSE:BDX) said today it won CE Mark approval in the European Union for its Vacutainer Barricor next-gen blood separation technology.
The Vacutainer Barricor tubes from Franklin Lakes, N.J.-based Becton Dickinson are single-use, plastic evacuated tubes used to collect, separate, transport and process venous blood specimens for obtaining high-quality plasma for in vitro diagnostic use, the company said.
“Laboratory technicians are forced to choose between a clean sample with serum and a fast sample with plasma. BD Barricor tubes eliminate this tradeoff, providing a cleaner and faster plasma sample than current methods,” global marketing veep & GM Lisa Nibauer said in prepared remarks.
The company said its Barricor tubes are designed to reduce cellular content as a result of the mechanical separator remaining open throughout the centrifugation cycle, eliminating gel artifacts found in plasma gel tubes.
Last month, BD said it won FDA 510(k) clearance for its FACSPresto system and CD4/Hb cartridge designed as an HIV/AIDS diagnostic.
The company’s system is designed as an automated multicolor fluorescent imaging cytometer and absorbance spectrometer, providing absolute and percentage results of CD4 T lymphocyte and hemoglobin concentration in blood samples.
The device uses a proprietary dried reagent cartridge which BD says increases stability across varied storage conditions. The system also includes a touch screen and allows for the processing of 80 tests in a day, with results available in less than 4 minutes.
The post Becton Dickinson wins CE Mark for blood separation tech appeared first on MassDevice.
from MassDevice http://ift.tt/1LtOTdt
Cap comentari:
Publica un comentari a l'entrada